Description
A selective PDE3 inhibitor with positive inotropic and vasodilating properties; induces relaxation of precontracted isolated human cavernous smooth muscle (IC50 = 4.2 μM); increases myocardial contractile force in anesthetized open-chest dogs in a dose-dependent manner at 10-300 μg/kg, as well as decreases systolic and diastolic blood pressure; inhibits DNA synthesis induced by PDGF-BB in bovine coronary artery smooth muscle cells in a concentration-dependent manner
Formal name: (3R)-6-chloro-1,5-dihydro-3-methyl-imidazo[2,1-b]quinazolin-2(3H)-one
Synonyms: Ro 13-6438
Molecular weight: 235.7
CAS: 70018-51-8
Purity: ≥98%
Formulation: A solid